Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

Multiplex Vaginal Panel (MVP) delivers faster identification of three distinct conditions within an hour SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ — Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert®…

Click here to view original post